2014‑07‑02 | I’ll Take Mine Rare |
2014‑07‑07 | Accelerated Aging |
2014‑07‑11 | Progression vs. Hardship |
2014‑07‑16 | Is There a Doctor in the House? |
2014‑07‑20 | Walking, Running, and Bicycling |
2014‑07‑23 | Bicycling with Ataxia |
2014‑08‑01 | This Is Exhausting |
2014‑10‑31 | The Unholy Trinity |
2014‑10‑31 | Tickler, Tickle Thyself |
2014‑12‑19 | Alternative Facts (Rarity, Part Two) |
2014‑12‑23 | SCA Terminology |
2015‑01‑23 | Terminology: Causes, Symptoms |
2015‑06‑24 | What Is Balance? |
2015‑10‑30 | Symptom? Disease? Disorder? |
2015‑11‑14 | Double Vision |
2015‑11‑16 | Playing the Piano |
2015‑11‑23 | Hear Me Play the Piano |
2015‑12‑08 | Prevalence and Incidence of Rare Diseases |
2015‑12‑23 | Rarity Again (Neurologists) |
2016‑05‑05 | Drug Repurposing |
2016‑06‑16 | Citalopram and SCA3 |
2016‑08‑29 | Unchained Malady |
2016‑09‑07 | Muddled Thoughts on a Cure |
2016‑10‑03 | Stranger in a Strange Land |
2016‑12‑12 | What is BHV‑4157? |
2017‑03‑09 | Clearer Thoughts on a Cure |
2017‑06‑22 | Vision Correction and Proprioception |
2017‑06‑24 | Shut Up, Genes (ASOs and RNAi) |
2017‑07‑03 | CRISPR and Crunchier |
2017‑07‑11 | Why I’m Skeptical of Troriluzole for SCA3 |
2017‑07‑14 | An Ounce of Prevention? |
2017‑07‑20 | Quel Che Sarà Sarà |
2017‑08‑22 | Stem Cell Terminology |
2017‑09‑12 | Can You Repeat That? |
2017‑11‑01 | How to Make a Treatment Seem Better Than It Is |
2017‑11‑10 | SCA Therapeutics Development |
2017‑11‑20 | FDA-Approved ASO Therapies as of 2017 |
2018‑05‑25 | Viral Delivery |
2018‑11‑09 | Terminology: When It’s Social |
2019‑05‑09 | Loose Screw |
2019‑06‑16 | How Do People Afford Million-Dollar Drugs in the U.S.? |
2019‑08‑07 | Terminology: Keep A-Knockin’ |
2019‑09‑24 | Terminology: Gene Therapy |
2019‑10‑31 | At Risk of Being Complete Nonsense |
2021‑02‑09 | (Vaccine) Efficacy |
Interactive pages
2015‑12‑08 | Prevalence and Incidence of Rare Diseases |
2015‑12‑26 | Prevalence of Ataxia |
2017‑07‑14 | Impact of SCA Prevention on SCA Prevalence |
Leave a Reply